ANAB earnings: a negative outcome, -5.8%

On March 11, 2024, AnaptysBio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.8% in the window around the event. It had already run +62.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.